Injectable magnesium oxychloride cement foam (mocf)-derived scaffold for treating osteoporotic bone defects
US-2024108785-A1 · Apr 4, 2024 · US
US10400019B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10400019-B2 |
| Application number | US-201515308285-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 1, 2015 |
| Priority date | May 1, 2014 |
| Publication date | Sep 3, 2019 |
| Grant date | Sep 3, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to keratin nanomaterials, methods for obtaining keratin nanomaterials, and biomaterials made from keratin nanomaterials. In particular, keratin nanomaterials comprising Type I and Type II monomer pairs are disclosed as well as a method for obtaining keratin nanomaterials comprising obtaining a solution of keratin and processing the solution by ultrafiltration with buffer solution containing phosphate.
Opening claim text (preview).
The invention claimed is: 1. A keratin nanomaterial comprising two (2) Type I and Type II monomer pairs, wherein the nanomaterial has a molecular size of approximately 50 nm in length and approximately 1 nm to 5 nm in diameter. 2. The keratin nanomaterial of claim 1 comprising a mixture of dimers and tetramers. 3. The keratin nanomaterial of claim 1 comprising a molecular complex essentially devoid of other proteins and/or peptides. 4. The keratin nanomaterial of claim 1 , wherein the nanomaterial has a molecular weight of greater than 100 kDa. 5. The keratin nanomaterial of claim 1 , wherein the nanomaterial has a molecular weight of greater than 200 kDa. 6. A keratin nanomaterial comprising two (2) Type I and Type II monomer pairs, wherein the nanomaterial has a molecular size of approximately 50 nm to 100 nm in length and approximately 5 nm to 10 nm in diameter. 7. A method for obtaining keratin nanomaterials comprising the following steps: a. obtaining a solution of keratins; b. processing the solution of keratins by ultrafiltration with buffer solution containing phosphate; and c. and further processing said solution by removing water to form a solid keratin nanomaterial of claim 1 or claim 6 . 8. The method of claim 7 , wherein the ultrafiltration is conducted with a NLMWCO membrane of 30 kDa. 9. The method of claim 7 , wherein the ultrafiltration is conducted with a NLMWCO membrane of 100 kDa. 10. The method of claim 7 , wherein the ultrafiltration is conducted with a NLMWCO membrane of 200 kDa. 11. The method of claim 7 , wherein the ultrafiltration is conducted with a NLMWCO membrane of 300 kDa. 12. The method of claim 7 , wherein the buffer solution containing phosphate comprises sodium phosphate. 13. The method of claim 7 , wherein the buffer solution containing phosphate comprises monosodium phosphate. 14. The method of claim 7 , wherein the buffer solution containing phosphate comprises disodium phosphate. 15. The method of claim 7 , wherein the buffer solution containing phosphate comprises potassium phosphate. 16. The method of claim 7 , wherein the buffer solution containing phosphate comprises monopotassium phosphate. 17. The method of claim 7 , wherein the buffer solution containing phosphate comprises dipotassium phosphate. 18. The method of claim 7 , wherein the buffer solution further comprises potassium chloride. 19. The keratin nanomaterial of claim 6 comprising a mixture of dimers and tetramers. 20. The keratin nanomaterial of claim 6 comprising a molecular complex essentially devoid of other proteins and/or peptides. 21. The keratin nanomaterial of claim 6 , wherein the nanomaterial has a molecular weight of greater than 100 kDa. 22. The keratin nanomaterial of claim 6 , wherein the nanomaterial has a molecular weight of greater than 200 kDa.
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces · CPC title
Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24 · CPC title
Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042 · CPC title
Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.